New agents in the Treatment of Myeloma Bone Disease.

about

Recent Trends and Advances in Cancer-Induced Bone Disease.Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

P2860

Q50014345-B552BBF8-8408-4473-8120-1D22C13698F4 Q58575853-C4207FE1-EF1C-4D6E-AA70-177BE3AF21D0

P2860

New agents in the Treatment of Myeloma Bone Disease.

Item

http://www.wikidata.org/entity/Q50323850

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

New agents in the Treatment of Myeloma Bone Disease.

@en

New agents in the Treatment of Myeloma Bone Disease.

@nl

type

Item

label

New agents in the Treatment of Myeloma Bone Disease.

@en

New agents in the Treatment of Myeloma Bone Disease.

@nl

prefLabel

New agents in the Treatment of Myeloma Bone Disease.

@en

New agents in the Treatment of Myeloma Bone Disease.

@nl

P1476

New agents in the Treatment of Myeloma Bone Disease.

@en

P2093

Andrew D Chantry

http://www.w3.org/2001/XMLSchema#string

Elizabeth S Ring

http://www.w3.org/2001/XMLSchema#string

Ingrid Jolley

http://www.w3.org/2001/XMLSchema#string

John A Snowden

http://www.w3.org/2001/XMLSchema#string

Michelle A Lawson

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells

Role of osteocytes in multiple myeloma bone disease

Diagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvement

Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling

Inorganic pyrophosphate generation and disposition in pathophysiology

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

Regulation of Wnt/β-catenin signaling within and from osteocytes

Cancer statistics, 2016

P2888

s00223-017-0351-7

P304

196-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00223-017-0351-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098361

http://www.w3.org/2001/XMLSchema#string

P921

multiple myeloma

bone disease

P932

5805798

http://www.w3.org/2001/XMLSchema#string

New agents in the Treatment of Myeloma Bone Disease.

about

P2860

P2860

New agents in the Treatment of Myeloma Bone Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932